207 related articles for article (PubMed ID: 30657917)
1. A Hyperandrogenic Environment Causes Intrinsic Defects That Are Detrimental to Follicular Dynamics in a PCOS Mouse Model.
Bertoldo MJ; Caldwell ASL; Riepsamen AH; Lin D; Gonzalez MB; Robker RL; Ledger WL; Gilchrist RB; Handelsman DJ; Walters KA
Endocrinology; 2019 Mar; 160(3):699-715. PubMed ID: 30657917
[TBL] [Abstract][Full Text] [Related]
2. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
3. Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization.
Foong SC; Abbott DH; Zschunke MA; Lesnick TG; Phy JL; Dumesic DA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2327-33. PubMed ID: 16551732
[TBL] [Abstract][Full Text] [Related]
4. Comparison of immunocytologic localization of insulin-like growth factor binding protein-4 in normal and polycystic ovary syndrome human ovaries.
Peng X; Maruo T; Samoto T; Mochizuki M
Endocr J; 1996 Jun; 43(3):269-78. PubMed ID: 8886620
[TBL] [Abstract][Full Text] [Related]
5. Decreased microRNA-125b-5p disrupts follicle steroidogenesis through targeting PAK3/ERK1/2 signalling in mouse preantral follicles.
Zhang X; Xiao H; Zhang X; E Q; Gong X; Li T; Han Y; Ying X; Cherrington BD; Xu B; Liu X; Zhang X
Metabolism; 2020 Jun; 107():154241. PubMed ID: 32304754
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology.
Teissier MP; Chable H; Paulhac S; Aubard Y
Hum Reprod; 1999 Sep; 14(9):2236-41. PubMed ID: 10469686
[TBL] [Abstract][Full Text] [Related]
7. Prolonged survival in culture of preantral follicles from polycystic ovaries.
Webber LJ; Stubbs SA; Stark J; Margara RA; Trew GH; Lavery SA; Hardy K; Franks S
J Clin Endocrinol Metab; 2007 May; 92(5):1975-8. PubMed ID: 17341570
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone suppresses excessive follicular development in murine preantral follicles.
Nagao S; Baba T; Fujibe Y; Adachi S; Ikeda K; Morishita M; Kuno Y; Honnma H; Endo T; Kiya T; Saito T
J Ovarian Res; 2019 Aug; 12(1):82. PubMed ID: 31472696
[TBL] [Abstract][Full Text] [Related]
9. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovarian condition in the dehydroepiandrosterone-treated rat model: hyperandrogenism and the resumption of meiosis are major initial events associated with cystogenesis of antral follicles.
Anderson E; Lee GY; O'Brien K
Anat Rec; 1997 Sep; 249(1):44-53. PubMed ID: 9294648
[TBL] [Abstract][Full Text] [Related]
11. Role of Insulin-like growth factors in initiation of follicle growth in normal and polycystic human ovaries.
Stubbs SA; Webber LJ; Stark J; Rice S; Margara R; Lavery S; Trew GH; Hardy K; Franks S
J Clin Endocrinol Metab; 2013 Aug; 98(8):3298-305. PubMed ID: 23750031
[TBL] [Abstract][Full Text] [Related]
12. An improved IVM method for cumulus-oocyte complexes from small follicles in polycystic ovary syndrome patients enhances oocyte competence and embryo yield.
Sánchez F; Lolicato F; Romero S; De Vos M; Van Ranst H; Verheyen G; Anckaert E; Smitz JEJ
Hum Reprod; 2017 Oct; 32(10):2056-2068. PubMed ID: 28938744
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
[TBL] [Abstract][Full Text] [Related]
14. Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome.
Tessaro I; Modina SC; Franciosi F; Sivelli G; Terzaghi L; Lodde V; Luciano AM
J Ovarian Res; 2015 Oct; 8():64. PubMed ID: 26437930
[TBL] [Abstract][Full Text] [Related]
15. [Polycystic ovary syndrome: A model of follicular excess].
Robin G; Catteau-Jonard S; Dewailly D; Decanter C
Gynecol Obstet Fertil; 2010 Jun; 38(6):405-8. PubMed ID: 20576552
[TBL] [Abstract][Full Text] [Related]
16. Implications of polycystic ovary syndrome on oocyte development.
Dumesic DA; Abbott DH
Semin Reprod Med; 2008 Jan; 26(1):53-61. PubMed ID: 18181083
[TBL] [Abstract][Full Text] [Related]
17. Endocrine traits of polycystic ovary syndrome in prenatally androgenized female Sprague-Dawley rats.
Wu XY; Li ZL; Wu CY; Liu YM; Lin H; Wang SH; Xiao WF
Endocr J; 2010; 57(3):201-9. PubMed ID: 20057162
[TBL] [Abstract][Full Text] [Related]
18. Follicle dynamics and anovulation in polycystic ovary syndrome.
Franks S; Stark J; Hardy K
Hum Reprod Update; 2008; 14(4):367-78. PubMed ID: 18499708
[TBL] [Abstract][Full Text] [Related]
19. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome.
Chen MJ; Yang WS; Chen CL; Wu MY; Yang YS; Ho HN
Hum Reprod; 2008 Apr; 23(4):952-7. PubMed ID: 18256110
[TBL] [Abstract][Full Text] [Related]
20. Direct actions of androgens on the survival, growth and secretion of steroids and anti-Müllerian hormone by individual macaque follicles during three-dimensional culture.
Rodrigues JK; Navarro PA; Zelinski MB; Stouffer RL; Xu J
Hum Reprod; 2015 Mar; 30(3):664-74. PubMed ID: 25567619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
